Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-440-9 | CAS number: 140-90-9
Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 30 days
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data on related xanthate provided as supporting information
Data source
Reference
- Reference Type:
- review article or handbook
- Title:
- Full Public Report Sodium Ethyl Xanthate Priority Existing Chemical No. 5
- Author:
- Australian Government Publishing Service Canberra
- Year:
- 1 995
- Bibliographic source:
- Australian Government Publishing Service Canberra
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Potassium O-pentyl dithiocarbonate
- EC Number:
- 220-329-5
- EC Name:
- Potassium O-pentyl dithiocarbonate
- Cas Number:
- 2720-73-2
- IUPAC Name:
- potassium O-pentyl dithiocarbonate
- Reference substance name:
- Potassium amyl xanthate
- IUPAC Name:
- Potassium amyl xanthate
- Test material form:
- aerosol dispenser: not specified
- Remarks:
- migrated information: aerosol
Constituent 1
Constituent 2
Test animals
- Species:
- dog
- Strain:
- Beagle
- Sex:
- male
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 30-day
- Frequency of treatment:
- 6 hrs daily, 5 days a week for a total of 20 exposures in 1 month
Doses / concentrationsopen allclose all
- Dose / conc.:
- 100 mg/m³ air (nominal)
- Dose / conc.:
- 800 mg/m³ air (nominal)
- No. of animals per sex per dose:
- 2
- Control animals:
- yes
Examinations
- Observations and examinations performed and frequency:
- Daily
Results and discussion
Results of examinations
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
Effect levels
- Dose descriptor:
- LOEC
- Effect level:
- 100 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male
- Basis for effect level:
- other: Hepatotoxic effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The results of this study indicate that potassium amyl xanthate has an adverse effect on the the liver in dogs. There were no treatment-related changes in the haematological or urinalysis values in any of the animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
